| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Hydralazine measurement |
Component |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing hydralazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine poisoning |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental hydralazine poisoning |
Causative agent (attribute) |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Intentional hydralazine poisoning |
Causative agent (attribute) |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Hydralazine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine adverse reaction |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to hydralazine (finding) |
Causative agent (attribute) |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Hydralazine overdose |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental hydralazine overdose |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Intentional hydralazine overdose |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine overdose of undetermined intent |
Causative agent (attribute) |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Hydralazine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| hydralazine hydrochloride 20 mg, fiole de poudre pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Drug-induced lupus erythematosus caused by hydralazine (disorder) |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine-induced pericarditis |
Causative agent (attribute) |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Hydralazine hydrochloride |
Is a |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Accidental hydralazine poisoning |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Intentional hydralazine poisoning |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing hydralazine and isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Hydralazine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to hydralazine (finding) |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
2 |
| Product containing hydralazine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine-induced pericarditis |
Causative agent (attribute) |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
2 |
| Hydralazine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
2 |
| Product containing hydralazine and isosorbide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
2 |
| Product containing hydralazine and isosorbide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
2 |
| Hydralazine- and hydrochlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing hydralazine and hydrochlorothiazide and reserpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydralazine and isosorbide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
2 |
| Hydralazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine and hydrochlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydralazine and hydrochlorothiazide and reserpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine (substance) |
Inferred relationship |
Some |
2 |
| Hydralazine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydralazine and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydralazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine-induced pericarditis |
Causative agent (attribute) |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing hydralazine and isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydralazine and isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Hydralazine- and isosorbide dinitrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]